🇺🇸 Metronizadole in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 12

Most-reported reactions

1. Dizziness — 2 reports (16.67%)
2. Headache — 2 reports (16.67%)
3. Blood Pressure Decreased — 1 report (8.33%)
4. Depressed Mood — 1 report (8.33%)
5. Dry Mouth — 1 report (8.33%)
6. Fatigue — 1 report (8.33%)
7. Insurance Issue — 1 report (8.33%)
8. Mood Swings — 1 report (8.33%)
9. Nausea — 1 report (8.33%)
10. Product Substitution Issue — 1 report (8.33%)

Source database →

Frequently asked questions

Is Metronizadole approved in United States?

Metronizadole does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metronizadole in United States?

University of Washington is the originator. The local marketing authorisation holder may differ — check the official source linked above.